Dr. Samir Kapadia
Claim this profileCleveland Clinic
Studies Mitral Regurgitation
Studies Mitral Valve Regurgitation
18 reported clinical trials
26 drugs studied
About Samir Kapadia
Education:
- Graduated with an MBBS (Bachelor of Medicine, Bachelor of Surgery) from Smt. NHL Municipal Medical College, Gujarat, India, in 1990.
Experience:
- Completed internship and residency in internal medicine at Baylor College of Medicine, Houston, earning the title of Outstanding Resident in 1993.
- Undertook fellowships in cardiology (1998) and interventional cardiology (2000) at Cleveland Clinic, Cleveland, where he was also the Chief Interventional Fellow.
- Worked as an interventional cardiologist at the VA Puget Sound Health Care System, Seattle, with an academic appointment at the University of Washington (2000–2003).
- Joined Cleveland Clinic as an interventional cardiologist in 2003, later becoming the Director of the Sones Cardiac Catheterization Laboratories in 2009 and Section Head of Invasive and Interventional Cardiology in 2014.
- Appointed Chairman of the Department of Cardiovascular Medicine at Cleveland Clinic in 2019.
Affiliated Hospitals
Clinical Trials Samir Kapadia is currently running
Transcatheter Valve Repair
for Mitral Regurgitation
This trial tests a new device called Edwards PASCAL that fixes leaky heart valves without surgery. It is for patients who can't have surgery or haven't improved with other treatments. The device helps the valve close better, stopping blood from leaking backward.
Recruiting1 award N/A9 criteria
Cardiac MRI
for Mitral Regurgitation
The goal of the current research is to develop personalized risk prediction for functional mitral regurgitation (FMR) patients through explainable unsupervised phenomapping enriched with advanced cardiac magnetic resonance (CMR) imaging biomarkers, and to determine the CMR predictors of reverse remodeling following modern therapies for FMR. The prospective study entails aiming to recruit 360 adult patients (ages \>18 years) with EF 10-50% and FMR RF\> 20%, who are clinically referred for CMR evaluation. Patients who enroll in our study will be referred for optimization of mGDMT and will undergo follow-up CMR studies at 6months. NICM patients who are fully medically optimized with significant FMR at the time of the baseline CMR and are referred for Mitraclip treatment will undergo follow-up CMR 6 months from Mitraclip intervention. NICM patients referred for mGDMT optimization, but have persistent or progressive FMR at the time of 6 month follow-up CMR and referred for Mitraclip therapy, will undergo a 2nd follow-up CMR 6 months from Mitraclip therapy.
Recruiting1 award N/A1 criteria
More about Samir Kapadia
Clinical Trial Related7 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Samir Kapadia has experience with
- V-Wave Shunt Placement
- Carillon Mitral Contour System
- Tendyne Mitral Valve System
- MitraClip System
- Phenotypic Classification Of FMR With CMR
- Intracardiac Echocardiography (ICE)
Breakdown of trials Samir Kapadia has run
Mitral Regurgitation
Mitral Valve Regurgitation
Valvular Heart Disease
Heart Failure
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Samir Kapadia specialize in?
Samir Kapadia focuses on Mitral Regurgitation and Mitral Valve Regurgitation. In particular, much of their work with Mitral Regurgitation has involved Stage III patients, or patients who are undergoing treatment.
Is Samir Kapadia currently recruiting for clinical trials?
Yes, Samir Kapadia is currently recruiting for 7 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Samir Kapadia has studied deeply?
Yes, Samir Kapadia has studied treatments such as V-Wave Shunt Placement, Carillon Mitral Contour System, Tendyne Mitral Valve System.
What is the best way to schedule an appointment with Samir Kapadia?
Apply for one of the trials that Samir Kapadia is conducting.
What is the office address of Samir Kapadia?
The office of Samir Kapadia is located at: Cleveland Clinic, Cleveland, Ohio 44195 United States. This is the address for their practice at the Cleveland Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.